… intervention and even towards prevention, biomarkers will gain significance as tools to aid
… and ultimately clinical practice. Keywords: Alzheimer’s disease, amyloid-β, biomarkers, tau …

… we foresee an increased use of these diagnostic tests in clinical routine practice. The AD
CSF biomarker toolbox has been expanded with novel biomarkers reflecting additional aspects …

… AD CSF biomarkers, as well as on the current clinical indications and … use of CSF biomarkers
in daily clinical practice. The diagnosis of Alzheimer’s disease relies on different biomarker …

… In this perspective, we review emerging biomarkers relevant to DMT drug development and
… advancing biomarkers for their use in clinical trials and their implementation in clinical care. …

… disease and its related pathologies. We also highlight the biomarkers that are currently in
clinical use and … with applying these biomarkers for diagnostic and prognostic purposes of …

… forces on disease-modifying trials and on endpoints for Alzheimer's disease clinical trials. …
art regarding the best use of biological markers in Alzheimer's disease therapy trials and to …

… ) biomarkers and their use in clinical trials with AD disease-modifying drug candidates. CSF
biomarkers … Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. …

… In this review, definitions of biomarkers are presented, the diverse uses of biomarkers …
role of biomarkers to assess efficacy of AD therapeutics is described. Individual biomarkers are …

… biomarkers of tau pathology in Alzheimer's disease, and discuss whether and how these tau
biomarkers can support the clinical … and how tau biomarkers can improve clinical trials of tau-…

… In this paper, we consider whether and how physicians should use CSF biomarkers in … We
present clinical cases to examine how CSF biomarkers could inform clinical practice decisions…